Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RRP9 and DDX21 as new biomarkers of colorectal cancer. | Medicine (Baltimore) | 2023 | 37904456 | PubTator, text mining | PubMed |
| The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells. | PLoS One | 2023 | 37903144 | PubTator, text mining | PubMed |
| Unleashing the Power of Synthetic Lethality: Augmenting Treatment Efficacy through Synergistic Integration with Chemotherapy Drugs. | Pharmaceutics | 2023 | 37896193 | PubTator, text mining | PubMed |
| Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells. | Cells | 2023 | 37887350 | PubTator, text mining | PubMed |
| Exploring Plant Meiosis: Insights from the Kinetochore Perspective. | Curr Issues Mol Biol | 2023 | 37886947 | PubTator, text mining | PubMed |
| HistoMIL: A Python package for training multiple instance learning models on histopathology slides. | iScience | 2023 | 37860768 | PubTator, text mining | PubMed |
| miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. | Noncoding RNA Res | 2023 | 37860266 | PubTator, text mining | PubMed |
| The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma. | Aging (Albany NY) | 2023 | 37851364 | PubTator, text mining | PubMed |
| Molecular landscape and functional characterization of centrosome amplification in ovarian cancer. | Nat Commun | 2023 | 37845213 | PubTator, text mining | PubMed |
| Resistance of breast cancer cells to paclitaxel is associated with low expressions of miRNA-186 and miRNA-7. | Cancer Drug Resist | 2023 | 37842231 | PubTator, text mining | PubMed |
| 3β-Hydroxy-12-oleanen-27-oic Acid Exerts an Antiproliferative Effect on Human Colon Carcinoma HCT116 Cells via Targeting FDFT1. | Int J Mol Sci | 2023 | 37834468 | PubTator, text mining | PubMed |
| Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification. | Int J Mol Sci | 2023 | 37834394 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer. | Front Immunol | 2023 | 37828981 | PubTator, text mining | PubMed |
| Retracted: miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1. | Comput Math Methods Med | 2023 | 37811302 | PubTator, text mining | PubMed |
| Targeting TRIP13 for overcoming anticancer drug resistance (Review). | Oncol Rep | 2023 | 37800638 | PubTator, text mining | PubMed |
| Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumors. | JCI Insight | 2023 | 37796616 | PubTator, text mining | PubMed |
| Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer. | J Funct Biomater | 2023 | 37754880 | PubTator, text mining | PubMed |
| MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex. | Oncogene | 2023 | 37752233 | PubTator, text mining | PubMed |
| Identification of early diagnostic biomarkers for breast cancer through bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37713876 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=10